← Back to Search

Other

Dressings Comparison for Donor Site Burns (AWBAT-D Trial)

N/A

Waitlist Available

Research Sponsored by Aubrey Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Burn wounds measuring 1% - 30% TBSA requiring skin grafting

Anterior bilateral donor sites of approximately the same size taken from the thighs or abdomen

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 year follow-up

Awards & highlights

AWBAT-D Trial Summary

This trial will compare the effectiveness of three types of dressings for healing wounds, infection rate, scarring, and pain perception.

Who is the study for?

This trial is for individuals with burn wounds covering 1% to 30% of their body, needing skin grafts from the thighs or abdomen. It's not suitable for those on ventilators, pregnant or breastfeeding women, people with conditions that could affect healing, and anyone allergic to porcine products.Check my eligibility

What is being tested?

The study aims to compare how well three different dressings help heal donor site burns. AWBAT™-D will be tested against Xeroform™ and Glucan II™ for healing speed, non-adherence, infection rates, scarring severity, and pain perception during treatment.See study design

What are the potential side effects?

Potential side effects may include discomfort at the dressing site, possible allergic reactions (especially important for those with known allergies to porcine products), risk of infection at the wound site, and varying degrees of scarring.

AWBAT-D Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have burns covering 1% to 30% of my body that need skin grafts.

Select...

I have similar-sized donor sites on my thighs or abdomen for surgery.

AWBAT-D Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 year follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 year follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 year follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

• To compare the rate of healing of donor sites. • To compare patient reported perception of pain • To compare the potential clinical complication rates of: o non-adherence, o seroma o hematoma o infection

Secondary outcome measures

• To compare clinical outcome of donor sites: scarring based on the Vancouver Scar Scale.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Aubrey Inc.Lead Sponsor

2 Previous Clinical Trials

30 Total Patients Enrolled

Media Library

AWBAT™-D (Other) Clinical Trial Eligibility Overview. Trial Name: NCT00964470 — N/A

Treatment of Donor Site Burns Research Study Groups:

Treatment of Donor Site Burns Clinical Trial 2023: AWBAT™-D Highlights & Side Effects. Trial Name: NCT00964470 — N/A

AWBAT™-D (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00964470 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is this experimentation open to elderly participants?

"This trial has established criteria for patient inclusion. Those aged 18 or above, and below 70 are eligible to participate."

Answered by AI

Are there any eligibility requirements for me to participate in this experiment?

"Sixty participants aged 18 to 70 with burn wounds measuring 1% - 30% TBSA requiring skin grafting are eligible for this therapeutic procedure."

Answered by AI

Is this research still recruiting participants?

"According to information available on clinicaltrials.gov, this particular medical trial is not currently enrolling patients; it was originally posted in August 2009 and last modified a full decade ago in June 2010. Despite this, there are still 74 other studies seeking participants at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery

2009. "Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00964470.

All > Tennessee > Paid Studies Ohio